img

Global Nerve Block Injection Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nerve Block Injection Market Insights, Forecast to 2034

Nerve block injection is a local anesthetic used during surgery to control pain and reduce or eliminate the use of opioids for acute postoperative pain.
Global Nerve Block Injection market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nerve Block Injection industry is evaluated to reach US$ million in 2034. The CAGR will be % during 2024 to 2034.
Globally, Nerve Block Injection key manufacturers include Pfizer, Pacira, Fresenius Kabi, Aspen Pharmacare, AstraZeneca, Eugia US, Aurobindo, Akorn and Somerset Pharma, etc. Pfizer, Pacira, Fresenius Kabi are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Nerve Block Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Nerve Block Injection market and estimated to attract more attentions from industry insiders and investors.
Nerve Block Injection can be divided into Esters Local Anesthetics and Amide Local Anesthetics, etc. Esters Local Anesthetics is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2034.
Nerve Block Injection is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Nerve Block Injection industry development. In 2022, global % sales of Nerve Block Injection went into Hospital filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Nerve Block Injection market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Nerve Block Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Pacira
Fresenius Kabi
Aspen Pharmacare
AstraZeneca
Eugia US
Aurobindo
Akorn
Somerset Pharma
Amphastar Pharmaceuticals
Hikma
Segment by Type
Esters Local Anesthetics
Amide Local Anesthetics

Segment by Application


Hospital
Clinic
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Nerve Block Injection plant distribution, commercial date of Nerve Block Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Nerve Block Injection introduction, etc. Nerve Block Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14QYResearch’s Conclusions of Nerve Block Injection
Chapter 15Methodology and Data Sources adopted by QYResearch

Table of Content

1 Study Coverage
1.1 Nerve Block Injection Product Introduction
1.2 Market by Type
1.2.1 Global Nerve Block Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Esters Local Anesthetics
1.2.3 Amide Local Anesthetics
1.3 Market by Application
1.3.1 Global Nerve Block Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nerve Block Injection Sales Estimates and Forecasts 2018-2034
2.2 Global Nerve Block Injection Revenue by Region
2.2.1 Global Nerve Block Injection Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Nerve Block Injection Revenue by Region (2018-2024)
2.2.3 Global Nerve Block Injection Revenue by Region (2024-2034)
2.2.4 Global Nerve Block Injection Revenue Market Share by Region (2018-2034)
2.3 Global Nerve Block Injection Sales Estimates and Forecasts 2018-2034
2.4 Global Nerve Block Injection Sales by Region
2.4.1 Global Nerve Block Injection Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Nerve Block Injection Sales by Region (2018-2024)
2.4.3 Global Nerve Block Injection Sales by Region (2024-2034)
2.4.4 Global Nerve Block Injection Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Nerve Block Injection Sales by Manufacturers
3.1.1 Global Nerve Block Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Nerve Block Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nerve Block Injection in 2022
3.2 Global Nerve Block Injection Revenue by Manufacturers
3.2.1 Global Nerve Block Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Nerve Block Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Nerve Block Injection Revenue in 2022
3.3 Global Key Players of Nerve Block Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Nerve Block Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Nerve Block Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Nerve Block Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Nerve Block Injection, Product Offered and Application
3.8 Global Key Manufacturers of Nerve Block Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nerve Block Injection Sales by Type
4.1.1 Global Nerve Block Injection Historical Sales by Type (2018-2024)
4.1.2 Global Nerve Block Injection Forecasted Sales by Type (2024-2034)
4.1.3 Global Nerve Block Injection Sales Market Share by Type (2018-2034)
4.2 Global Nerve Block Injection Revenue by Type
4.2.1 Global Nerve Block Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Nerve Block Injection Forecasted Revenue by Type (2024-2034)
4.2.3 Global Nerve Block Injection Revenue Market Share by Type (2018-2034)
4.3 Global Nerve Block Injection Price by Type
4.3.1 Global Nerve Block Injection Price by Type (2018-2024)
4.3.2 Global Nerve Block Injection Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Nerve Block Injection Sales by Application
5.1.1 Global Nerve Block Injection Historical Sales by Application (2018-2024)
5.1.2 Global Nerve Block Injection Forecasted Sales by Application (2024-2034)
5.1.3 Global Nerve Block Injection Sales Market Share by Application (2018-2034)
5.2 Global Nerve Block Injection Revenue by Application
5.2.1 Global Nerve Block Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Nerve Block Injection Forecasted Revenue by Application (2024-2034)
5.2.3 Global Nerve Block Injection Revenue Market Share by Application (2018-2034)
5.3 Global Nerve Block Injection Price by Application
5.3.1 Global Nerve Block Injection Price by Application (2018-2024)
5.3.2 Global Nerve Block Injection Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Nerve Block Injection Market Size by Type
6.1.1 US & Canada Nerve Block Injection Sales by Type (2018-2034)
6.1.2 US & Canada Nerve Block Injection Revenue by Type (2018-2034)
6.2 US & Canada Nerve Block Injection Market Size by Application
6.2.1 US & Canada Nerve Block Injection Sales by Application (2018-2034)
6.2.2 US & Canada Nerve Block Injection Revenue by Application (2018-2034)
6.3 US & Canada Nerve Block Injection Market Size by Country
6.3.1 US & Canada Nerve Block Injection Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Nerve Block Injection Sales by Country (2018-2034)
6.3.3 US & Canada Nerve Block Injection Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Nerve Block Injection Market Size by Type
7.1.1 Europe Nerve Block Injection Sales by Type (2018-2034)
7.1.2 Europe Nerve Block Injection Revenue by Type (2018-2034)
7.2 Europe Nerve Block Injection Market Size by Application
7.2.1 Europe Nerve Block Injection Sales by Application (2018-2034)
7.2.2 Europe Nerve Block Injection Revenue by Application (2018-2034)
7.3 Europe Nerve Block Injection Market Size by Country
7.3.1 Europe Nerve Block Injection Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Nerve Block Injection Sales by Country (2018-2034)
7.3.3 Europe Nerve Block Injection Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Nerve Block Injection Market Size
8.1.1 China Nerve Block Injection Sales (2018-2034)
8.1.2 China Nerve Block Injection Revenue (2018-2034)
8.2 China Nerve Block Injection Market Size by Application
8.2.1 China Nerve Block Injection Sales by Application (2018-2034)
8.2.2 China Nerve Block Injection Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Nerve Block Injection Market Size by Type
9.1.1 Asia Nerve Block Injection Sales by Type (2018-2034)
9.1.2 Asia Nerve Block Injection Revenue by Type (2018-2034)
9.2 Asia Nerve Block Injection Market Size by Application
9.2.1 Asia Nerve Block Injection Sales by Application (2018-2034)
9.2.2 Asia Nerve Block Injection Revenue by Application (2018-2034)
9.3 Asia Nerve Block Injection Sales by Region
9.3.1 Asia Nerve Block Injection Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Nerve Block Injection Revenue by Region (2018-2034)
9.3.3 Asia Nerve Block Injection Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Nerve Block Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Nerve Block Injection Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Nerve Block Injection Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Nerve Block Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Nerve Block Injection Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Nerve Block Injection Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Nerve Block Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Nerve Block Injection Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Nerve Block Injection Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Nerve Block Injection Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Pacira
11.2.1 Pacira Company Information
11.2.2 Pacira Overview
11.2.3 Pacira Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pacira Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pacira Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Fresenius Kabi Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Aspen Pharmacare
11.4.1 Aspen Pharmacare Company Information
11.4.2 Aspen Pharmacare Overview
11.4.3 Aspen Pharmacare Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Aspen Pharmacare Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Aspen Pharmacare Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 AstraZeneca Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Eugia US
11.6.1 Eugia US Company Information
11.6.2 Eugia US Overview
11.6.3 Eugia US Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Eugia US Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eugia US Recent Developments
11.7 Aurobindo
11.7.1 Aurobindo Company Information
11.7.2 Aurobindo Overview
11.7.3 Aurobindo Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Aurobindo Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurobindo Recent Developments
11.8 Akorn
11.8.1 Akorn Company Information
11.8.2 Akorn Overview
11.8.3 Akorn Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Akorn Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Akorn Recent Developments
11.9 Somerset Pharma
11.9.1 Somerset Pharma Company Information
11.9.2 Somerset Pharma Overview
11.9.3 Somerset Pharma Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Somerset Pharma Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Somerset Pharma Recent Developments
11.10 Amphastar Pharmaceuticals
11.10.1 Amphastar Pharmaceuticals Company Information
11.10.2 Amphastar Pharmaceuticals Overview
11.10.3 Amphastar Pharmaceuticals Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Amphastar Pharmaceuticals Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amphastar Pharmaceuticals Recent Developments
11.11 Hikma
11.11.1 Hikma Company Information
11.11.2 Hikma Overview
11.11.3 Hikma Nerve Block Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hikma Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hikma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nerve Block Injection Industry Chain Analysis
12.2 Nerve Block Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nerve Block Injection Production Mode & Process
12.4 Nerve Block Injection Sales and Marketing
12.4.1 Nerve Block Injection Sales Channels
12.4.2 Nerve Block Injection Distributors
12.5 Nerve Block Injection Customers
13 Market Dynamics
13.1 Nerve Block Injection Industry Trends
13.2 Nerve Block Injection Market Drivers
13.3 Nerve Block Injection Market Challenges
13.4 Nerve Block Injection Market Restraints
14 Key Findings in The Global Nerve Block Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Nerve Block Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Esters Local Anesthetics
Table 3. Major Manufacturers of Amide Local Anesthetics
Table 4. Global Nerve Block Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Nerve Block Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Nerve Block Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Nerve Block Injection Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Nerve Block Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Nerve Block Injection Revenue Market Share by Region (2024-2034)
Table 10. Global Nerve Block Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Nerve Block Injection Sales by Region (2018-2024) & (K Units)
Table 12. Global Nerve Block Injection Sales by Region (2024-2034) & (K Units)
Table 13. Global Nerve Block Injection Sales Market Share by Region (2018-2024)
Table 14. Global Nerve Block Injection Sales Market Share by Region (2024-2034)
Table 15. Global Nerve Block Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Nerve Block Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Nerve Block Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Nerve Block Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Nerve Block Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Nerve Block Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Nerve Block Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Nerve Block Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nerve Block Injection as of 2022)
Table 23. Global Key Manufacturers of Nerve Block Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Nerve Block Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Nerve Block Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 28. Global Nerve Block Injection Sales by Type (2024-2034) & (K Units)
Table 29. Global Nerve Block Injection Sales Share by Type (2018-2024)
Table 30. Global Nerve Block Injection Sales Share by Type (2024-2034)
Table 31. Global Nerve Block Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Nerve Block Injection Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Nerve Block Injection Revenue Share by Type (2018-2024)
Table 34. Global Nerve Block Injection Revenue Share by Type (2024-2034)
Table 35. Nerve Block Injection Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Nerve Block Injection Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Nerve Block Injection Sales by Application (2018-2024) & (K Units)
Table 38. Global Nerve Block Injection Sales by Application (2024-2034) & (K Units)
Table 39. Global Nerve Block Injection Sales Share by Application (2018-2024)
Table 40. Global Nerve Block Injection Sales Share by Application (2024-2034)
Table 41. Global Nerve Block Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Nerve Block Injection Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Nerve Block Injection Revenue Share by Application (2018-2024)
Table 44. Global Nerve Block Injection Revenue Share by Application (2024-2034)
Table 45. Nerve Block Injection Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Nerve Block Injection Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Nerve Block Injection Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Nerve Block Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Nerve Block Injection Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Nerve Block Injection Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Nerve Block Injection Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Nerve Block Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Nerve Block Injection Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Nerve Block Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Nerve Block Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Nerve Block Injection Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 60. Europe Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 61. Europe Nerve Block Injection Sales by Type (2024-2034) & (K Units)
Table 62. Europe Nerve Block Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Nerve Block Injection Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Nerve Block Injection Sales by Application (2018-2024) & (K Units)
Table 65. Europe Nerve Block Injection Sales by Application (2024-2034) & (K Units)
Table 66. Europe Nerve Block Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Nerve Block Injection Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Nerve Block Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Nerve Block Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Nerve Block Injection Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 72. Europe Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 73. China Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 74. China Nerve Block Injection Sales by Type (2024-2034) & (K Units)
Table 75. China Nerve Block Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Nerve Block Injection Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Nerve Block Injection Sales by Application (2018-2024) & (K Units)
Table 78. China Nerve Block Injection Sales by Application (2024-2034) & (K Units)
Table 79. China Nerve Block Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Nerve Block Injection Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 82. Asia Nerve Block Injection Sales by Type (2024-2034) & (K Units)
Table 83. Asia Nerve Block Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Nerve Block Injection Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Nerve Block Injection Sales by Application (2018-2024) & (K Units)
Table 86. Asia Nerve Block Injection Sales by Application (2024-2034) & (K Units)
Table 87. Asia Nerve Block Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Nerve Block Injection Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Nerve Block Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Nerve Block Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Nerve Block Injection Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Nerve Block Injection Sales by Region (2018-2024) & (K Units)
Table 93. Asia Nerve Block Injection Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Nerve Block Injection Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Nerve Block Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Nerve Block Injection Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Nerve Block Injection Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Nerve Block Injection Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Nerve Block Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Nerve Block Injection Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Nerve Block Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Nerve Block Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Nerve Block Injection Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Pacira Company Information
Table 113. Pacira Description and Major Businesses
Table 114. Pacira Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Pacira Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pacira Recent Developments
Table 117. Fresenius Kabi Company Information
Table 118. Fresenius Kabi Description and Major Businesses
Table 119. Fresenius Kabi Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Fresenius Kabi Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Fresenius Kabi Recent Developments
Table 122. Aspen Pharmacare Company Information
Table 123. Aspen Pharmacare Description and Major Businesses
Table 124. Aspen Pharmacare Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Aspen Pharmacare Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Aspen Pharmacare Recent Developments
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. AstraZeneca Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AstraZeneca Recent Developments
Table 132. Eugia US Company Information
Table 133. Eugia US Description and Major Businesses
Table 134. Eugia US Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Eugia US Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eugia US Recent Developments
Table 137. Aurobindo Company Information
Table 138. Aurobindo Description and Major Businesses
Table 139. Aurobindo Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Aurobindo Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Aurobindo Recent Developments
Table 142. Akorn Company Information
Table 143. Akorn Description and Major Businesses
Table 144. Akorn Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Akorn Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Akorn Recent Developments
Table 147. Somerset Pharma Company Information
Table 148. Somerset Pharma Description and Major Businesses
Table 149. Somerset Pharma Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Somerset Pharma Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Somerset Pharma Recent Developments
Table 152. Amphastar Pharmaceuticals Company Information
Table 153. Amphastar Pharmaceuticals Description and Major Businesses
Table 154. Amphastar Pharmaceuticals Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Amphastar Pharmaceuticals Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Amphastar Pharmaceuticals Recent Developments
Table 157. Hikma Company Information
Table 158. Hikma Description and Major Businesses
Table 159. Hikma Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Hikma Nerve Block Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hikma Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Nerve Block Injection Distributors List
Table 165. Nerve Block Injection Customers List
Table 166. Nerve Block Injection Market Trends
Table 167. Nerve Block Injection Market Drivers
Table 168. Nerve Block Injection Market Challenges
Table 169. Nerve Block Injection Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Nerve Block Injection Product Picture
Figure 2. Global Nerve Block Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nerve Block Injection Market Share by Type in 2022 & 2034
Figure 4. Esters Local Anesthetics Product Picture
Figure 5. Amide Local Anesthetics Product Picture
Figure 6. Global Nerve Block Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Nerve Block Injection Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Nerve Block Injection Report Years Considered
Figure 12. Global Nerve Block Injection Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Nerve Block Injection Revenue 2018-2034 (US$ Million)
Figure 14. Global Nerve Block Injection Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Nerve Block Injection Revenue Market Share by Region (2018-2034)
Figure 16. Global Nerve Block Injection Sales 2018-2034 ((K Units)
Figure 17. Global Nerve Block Injection Sales Market Share by Region (2018-2034)
Figure 18. US & Canada Nerve Block Injection Sales YoY (2018-2034) & (K Units)
Figure 19. US & Canada Nerve Block Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Nerve Block Injection Sales YoY (2018-2034) & (K Units)
Figure 21. Europe Nerve Block Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Nerve Block Injection Sales YoY (2018-2034) & (K Units)
Figure 23. China Nerve Block Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Asia (excluding China) Nerve Block Injection Sales YoY (2018-2034) & (K Units)
Figure 25. Asia (excluding China) Nerve Block Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Nerve Block Injection Sales YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Nerve Block Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Nerve Block Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Nerve Block Injection in the World: Market Share by Nerve Block Injection Revenue in 2022
Figure 30. Global Nerve Block Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Nerve Block Injection Sales Market Share by Type (2018-2034)
Figure 32. Global Nerve Block Injection Revenue Market Share by Type (2018-2034)
Figure 33. Global Nerve Block Injection Sales Market Share by Application (2018-2034)
Figure 34. Global Nerve Block Injection Revenue Market Share by Application (2018-2034)
Figure 35. US & Canada Nerve Block Injection Sales Market Share by Type (2018-2034)
Figure 36. US & Canada Nerve Block Injection Revenue Market Share by Type (2018-2034)
Figure 37. US & Canada Nerve Block Injection Sales Market Share by Application (2018-2034)
Figure 38. US & Canada Nerve Block Injection Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Nerve Block Injection Revenue Share by Country (2018-2034)
Figure 40. US & Canada Nerve Block Injection Sales Share by Country (2018-2034)
Figure 41. U.S. Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 42. Canada Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 43. Europe Nerve Block Injection Sales Market Share by Type (2018-2034)
Figure 44. Europe Nerve Block Injection Revenue Market Share by Type (2018-2034)
Figure 45. Europe Nerve Block Injection Sales Market Share by Application (2018-2034)
Figure 46. Europe Nerve Block Injection Revenue Market Share by Application (2018-2034)
Figure 47. Europe Nerve Block Injection Revenue Share by Country (2018-2034)
Figure 48. Europe Nerve Block Injection Sales Share by Country (2018-2034)
Figure 49. Germany Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 50. France Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 51. U.K. Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 52. Italy Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 53. Russia Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 54. China Nerve Block Injection Sales Market Share by Type (2018-2034)
Figure 55. China Nerve Block Injection Revenue Market Share by Type (2018-2034)
Figure 56. China Nerve Block Injection Sales Market Share by Application (2018-2034)
Figure 57. China Nerve Block Injection Revenue Market Share by Application (2018-2034)
Figure 58. Asia Nerve Block Injection Sales Market Share by Type (2018-2034)
Figure 59. Asia Nerve Block Injection Revenue Market Share by Type (2018-2034)
Figure 60. Asia Nerve Block Injection Sales Market Share by Application (2018-2034)
Figure 61. Asia Nerve Block Injection Revenue Market Share by Application (2018-2034)
Figure 62. Asia Nerve Block Injection Revenue Share by Region (2018-2034)
Figure 63. Asia Nerve Block Injection Sales Share by Region (2018-2034)
Figure 64. Japan Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 65. South Korea Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 66. China Taiwan Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 67. Southeast Asia Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 68. India Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Nerve Block Injection Sales Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Nerve Block Injection Revenue Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Nerve Block Injection Sales Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Nerve Block Injection Revenue Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Nerve Block Injection Revenue Share by Country (2018-2034)
Figure 74. Middle East, Africa and Latin America Nerve Block Injection Sales Share by Country (2018-2034)
Figure 75. Brazil Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 76. Mexico Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 77. Turkey Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 78. Israel Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 79. GCC Countries Nerve Block Injection Revenue (2018-2034) & (US$ Million)
Figure 80. Nerve Block Injection Value Chain
Figure 81. Nerve Block Injection Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed